can tirzepatide cause pancreatic cancer Scientists have discovered that tirzepatide—an FDA-approved drug for diabetes and weight loss (Mounjaro, Zepbound)—can also shrink breast tumors in obese mice. Presented at ENDO 2025, the University of Michigan study showed Tirzepatide: A Promising Drug for
Description
Precision biomaterials in cancer theranostics and modelling

A., Sullivan A

Thomas and colleagues at Eli Lilly and Company, [76] investigate the impact of tirzepatide on beta-cell function and insulin sensitivity in individuals with type 2 diabetes

This challenges the common assumption that tablets are automatically less effective than injections
